secwatch.observer — SEC 8-K summary
======================================

Issuer:     INDEPENDENT BANK CORP (INDB)
CIK:        0000776901
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0000776901-26-000061
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INDB CEO Jeff Tengel diagnosed with lymphoma, expects full recovery, will continue working
--------------------------------------------------------------------------------

- CEO Jeffrey Tengel disclosed a Lymphoma diagnosis; has begun chemotherapy.
- Tengel expects full recovery, plans to continue working with schedule adjustments.
- Board and Executive Leadership Team are fully supportive; strategy remains unchanged.
- Tengel may reduce attendance at large gatherings during treatment for health precautions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/776901/000077690126000061/0000776901-26-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/776901/000077690126000061/indb-20260304.htm
  HTML page:      https://secwatch.observer/filing/0000776901-26-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer